Plain-English translation of NCT07009171 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase 2 clinical trial testing a new medication called to see if it can help adults with obesity or overweight lose weight. The study will follow about 75 people over three stages, carefully increasing the dose of the medication in each stage. Researchers want to find the best dose that works well and is safe.
Obesity is a serious health challenge, and many people struggle to lose weight even with diet and exercise alone. This medication is being tested because early research suggests it may help people lose weight by affecting how the brain controls appetite and metabolism.
You likely qualify if…
You likely don't qualify if…
You would start with a 2-week preparation period where you practice healthy eating and exercise habits to see if you can maintain them. Then you would take one daily pill for 12 weeks—either the new medication at a certain dose or a placebo (dummy pill) that looks identical. You would visit the clinic at weeks 4, 8, and 12, have a phone call at week 2, and one final phone check-in at week 13. Throughout the study, researchers will measure your weight, take blood samples, and check how you are feeling.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
South Korea